Biotech China 2014

View Profile


Pre/Non Reviewed Papers, Proceedings

Year Title Authors
1. 2009 Serum Mass Spectrometry Profiling of Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.
2. 2009 Effect of insulin-like growth factor 1 receptor inhibitor on sensitization of head and neck cancer cells to cetuximab and methotrexate
3. 2009 Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129
4. 2009 Mass spectrometry profile as a predictor of overall survival benefit after treatment with epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma.
5. 2009 Cetuximab sensitivity in head and neck squamous cell carcinoma cell lines based on the HPV status
6. 2008 Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma.
7. 2008 Growth inhibition and activation of the oxidative stress signaling pathway by 17-AAG in head and neck squamous cell carcinoma.
8. 2008 Hypothyroidism as a consequence of intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC).”
9. 2008 Head and neck cancer (HNC), depression, and genetic polymorphism.
10. 2008 Gene expression profile of pemetrexed and oxaliplatin response in a phase II induction trial in locally advanced head and neck squamous cell carcinoma
11. 2008 Protein Kinase C alpha promotes tumor growth by initiating a feed-forward network involving miR15a and Cyclin E deregulation
12. 2007 A Dynamic Network involving Protein Kinase C alpha Regulation of E2F2 and Cyclin E in Squamous Cell Carcinoma of the Head and Neck.
13. 2007 A differentiation based immunohistochemistry classifier that is prognostic for head and neck tumor patients
14. 2007 Activated EGFR signature correlates with presence of the increased EGFR gene copy number in HNSCC
15. 2007 Cetuximab-related hypersensitivity reactions associated with pre-existing cetuximab-specific IgE antibody
16. 2007 Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck
17. 2006 High gene copy number of epidermal growth factor receptor by fluorescence in situ hybridization is frequent in head and neck squamous cell carcinomas and associates with worse recurrence-free survival
18. 2005 Human Papilloma Virus and gene expression profiles in head and neck squamous cell carcinoma
19. 2005 Survival prediction of head and neck squamous cell carcinoma based on gene expression analysis using formalin-fixed paraffin-embedded tissue
20. 2005 Intensity-modulated radiation therapy with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer: Feasibility, technique and toxicities.
21. 2005 Gene expression analysis of head and neck squamous cell carcinoma using formalin-fixed paraffin embedded tissue.
22. 2004 Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck (RMHNC
23. 2004 Gene expression analyses as a prognosticator of survival in head and neck squamous cell carcinoma.
24. 2004 Predicting psychosocial well-being in head and neck cancer (HNC).
25. 2003 Gene expression as a predictor of metastasis in head and neck squamous cell carcinoma
26. 2003 Cervical lymph node metastasis prediction in head and neck squamous cell carcinoma based on its gene expression.
27. 2000 Identification of a 3.4 Kb Alu-mediated deletion in BRCT domain of BRCA1 gene in an ovarian cancer patient
28. 1996 Detection of K-ras mutations in duodenal fluid-derived DNA from patients with pancreatic cancer


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.